Wong Kelvin, Briddon Stephen J, Holliday Nicholas D, Kerr Ian D
Cell Signalling Research Group, School of Life Sciences, Queen's Medical Centre, University of Nottingham, NG7 2UH, UK.
Cell Signalling Research Group, School of Life Sciences, Queen's Medical Centre, University of Nottingham, NG7 2UH, UK.
Biochim Biophys Acta. 2016 Jan;1863(1):19-29. doi: 10.1016/j.bbamcr.2015.10.002. Epub 2015 Oct 8.
ABCG2 is one of three human ATP binding cassette (ABC) transporters involved in the export from cells of a chemically and structurally diverse range of compounds. This multidrug efflux capability, together with a broad tissue distribution in the body, means that ABCG2 exerts a range of effects on normal physiology such as kidney urate transport, as well as contributing towards the pharmacokinetic profiles of many exogenous drugs. The primary sequence of ABCG2 contains only half the number of domains required for a functioning ABC transporter and so it must oligomerise in order to function, yet its oligomeric state in intact cell membranes remains uncharacterized. We have analysed ABCG2 in living cell membranes using a combination of fluorescence correlation spectroscopy, photon counting histogram analysis, and stepwise photobleaching to demonstrate a predominantly tetrameric structure for ABCG2 in the presence or absence of transport substrates. These results provide the essential basis for exploring pharmacological manipulation of oligomeric state as a strategy to modulate ABCG2 activity in future selective therapeutics.
ABCG2是参与从细胞中输出化学结构多样的一系列化合物的三种人类ATP结合盒(ABC)转运蛋白之一。这种多药外排能力,以及在体内广泛的组织分布,意味着ABCG2对正常生理功能有一系列影响,如肾脏尿酸转运,同时也影响许多外源性药物的药代动力学特征。ABCG2的一级序列仅包含功能性ABC转运蛋白所需结构域数量的一半,因此它必须寡聚化才能发挥作用,但其在完整细胞膜中的寡聚状态仍未明确。我们使用荧光相关光谱、光子计数直方图分析和逐步光漂白相结合的方法,对活细胞膜中的ABCG2进行了分析,以证明在存在或不存在转运底物的情况下,ABCG2主要以四聚体结构存在。这些结果为探索将寡聚状态的药理调控作为未来选择性治疗中调节ABCG2活性的策略提供了重要依据。